Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:12:47.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Updates to the study record dates show new entries on 2026-03-02, 2026-02-26, and 2026-02 and removal of entries on 2025-12-24, 2025-12-08, and 2025-12, indicating revisions to the trial information.
    Difference
    0.2%
    Check dated 2026-03-04T15:16:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Footer and navigation updates removed references to the Moffitt Cancer Center Clinical Trials website and the H. Lee Moffitt Cancer Center and Research Institute. A new Revision: v3.4.2 tag was added.
    Difference
    0.6%
    Check dated 2026-02-11T05:50:38.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice was added and the revision stamp updated to v3.4.1 (replacing the previous v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:46:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option and new/updated metadata fields (Last Update Submitted that Met QC Criteria and Last Update Posted) with a footer Revision: v3.4.0. Removed or revised items include No FEAR Act data and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T03:25:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.3.4, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:27:39.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.